Herpes zoster after autologous hematopoietic stem cell transplantation

dc.citation.epage301pt_BR
dc.citation.issue4pt_BR
dc.citation.spage298pt_BR
dc.citation.volume38pt_BR
dc.creatorSantos, Kelli Borges dos
dc.creatorSouza, Rafaela Souto e
dc.creatorAtalla, Angelo
dc.creatorHallack Neto, Abrahão Elias
dc.date.accessioned2018-09-11T13:31:06Z
dc.date.available2018-09-11
dc.date.available2018-09-11T13:31:06Z
dc.date.issued2016-10
dc.description.abstractBackground: The autologous hematopoietic stem cell transplantation procedure involves immunosuppression of the patient. Thus, the patient has an elevated risk for several diseases, such as infections with the varicella-zoster virus. Prevention protocols have been proposed based on the use of acyclovir from the first day of conditioning, and maintaining this drug for 30-100 days after the procedure or for as much as one year. The objective of this work was to evaluate the incidence of herpes zoster after autologous transplantations related to the early suspension of acyclovir. Methods:A retrospective study was carried out based on the collection of data from 231 medical records of transplant patients in the Bone Marrow Transplant Unit of the teaching hospital of the Universidade Federal de Juiz de Fora in the period between 2004 and 2014. Results: Fourteen (6.1%) patients had herpes zoster in the post-transplant period on average within six months of the procedure. Patients with multiple myeloma (64.3%) were the most affected. There was a statistically significant difference in the age of the patients, with older individuals having a greater chance of developing the infection (p-value = 0.002). There were no significant differences for the other variables analyzed. Conclusion: The early suspension of acyclovir can be safe in patients who receive autologous hematopoietic stem cell transplants. However some groups may benefit from extended prophylaxis with acyclovir, particularly older patients and patients with multiple myeloma.pt_BR
dc.description.resumo-pt_BR
dc.identifier.doihttp://dx.doi.org/10.1016/j.bjhh.2016.05.015pt_BR
dc.identifier.urihttps://repositorio.ufjf.br/handle/ufjf/7412
dc.languageengpt_BR
dc.publisher-pt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.initials-pt_BR
dc.relation.ispartofRevista Brasileira de Hematologia e Hemoterapiapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectTransplant of hematopoietic stem cellspt_BR
dc.subjectAutologouspt_BR
dc.subjectHerpes zosterpt_BR
dc.subjectPrevention and controlpt_BR
dc.subject.cnpq-pt_BR
dc.titleHerpes zoster after autologous hematopoietic stem cell transplantationpt_BR
dc.typeArtigo de Periódicopt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Herpes zoster after autologous hematopoietic stem cell transplantation.pdf
Size:
258.48 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.15 KB
Format:
Item-specific license agreed upon to submission
Description: